ClinicalTrials.Veeva

Menu

Special Drug Use-results Survey for Long-term Use(Avacopan)

Kissei logo

Kissei

Status

Enrolling

Conditions

Granulomatosis With Polyangiitis (GPA)
Microscopic Polyangiitis (MPA)

Treatments

Drug: Avacopan

Study type

Observational

Funder types

Industry

Identifiers

NCT06758271
TVPMS01

Details and patient eligibility

About

The purpose of this survey is evaluating the safety and efficacy of long-term administration of avacopan for Japanese patients with microscopic polyangiitis or granulomatosis with polyangiitis under actual conditions of use.

Full description

The purpose of this survey is evaluating the safety and efficacy of long-term administration of avacopan for Japanese patients with microscopic polyangiitis or granulomatosis with polyangiitis under actual conditions of use.

Enrollment

250 estimated patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

  • Patients with granulomatosis with polyangiitis or microscopic polyangiitis who are treatment with avacopan

Trial design

250 participants in 1 patient group

Avacopan treatmented
Treatment:
Drug: Avacopan

Trial contacts and locations

1

Loading...

Central trial contact

Kazunori Abe, director

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems